Skip to content
  • Investor Dashboard
  • Manufacturing
BioStem logoBioStem logo
  • Home
  • Our Science
  • ProductsExpand
    • VENDAJE®
    • VENDAJE AC®
    • VENDAJE OPTIC®
    • American Amnion
  • Resources
  • About UsExpand
    • Careers
    • Events
CONTACT US

Investor Dashboard | Manufacturing

BioStem logo

  • Press Release

    BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers

    ByJohn Garica June 23, 2025June 23, 2025

    Jun 23, 2025 Head-to-head study comparing BioREtain®– processed Amnion Chorion (BR-AC) allograft to standard of care initiated in Q4 2024 to demonstrate healing superiority Topline results and full data analysis…

    Read More BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot UlcersContinue

  • Press Release

    Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner

    ByJohn Garica June 17, 2025June 17, 2025

    Award celebrates bold leaders shaping the future through the world’s most ground-breaking companies. Source: BioStem Technologies, Inc. POMPANO BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) — Ernst & Young LLP (EY…

    Read More Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award WinnerContinue

  • Blog

    BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process

    ByJohn Garica June 3, 2025June 3, 2025

    Upon SEC approval of the amended Form 10, BioStem expects to advance its uplisting to Nasdaq POMPANO BEACH, Fla. – June 3, 2025 – (GLOBE NEWSWIRE) — BioStem Technologies, Inc….

    Read More BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review ProcessContinue

  • Blog

    Beyond Traditional Wound Care: How Amniotic Tissue is Changing VLU Treatment

    ByJohn Garica May 30, 2025May 30, 2025

    Venous leg ulcers (VLUs) are a significant health concern in the United States, affecting approximately 1% to 3% of the population. This prevalence increases to about 4% among adults aged…

    Read More Beyond Traditional Wound Care: How Amniotic Tissue is Changing VLU TreatmentContinue

  • Press Release

    BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

    ByJohn Garica May 29, 2025May 29, 2025

    POMPANO BEACH, Fla., May 29, 2025 (GLOBE NEWSWIRE) —BioStem Technologies, Inc.(OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care,…

    Read More BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare ConferenceContinue

  • Press Release

    BioStem Announces Notice of Allowance for Three New U.S. Patent Applications

    ByJohn Garica May 28, 2025

    Expanding patent portfolio reinforces the Company’s commitment to wound care innovation, with 55 issued patents and 52 pending applications POMPANO BEACH, Fla., May 28, 2025 (GLOBE NEWSWIRE) — BioStem Technologies,…

    Read More BioStem Announces Notice of Allowance for Three New U.S. Patent ApplicationsContinue

  • Press Release

    Ernst & Young (EY) US Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award finalist

    ByJohn Garica May 22, 2025May 22, 2025

    May 22, 2025Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future POMPANO BEACH, Fla., May 22, 2025 (GLOBE NEWSWIRE) —BioStem Technologies, Inc.(OTC: BSEM) (the “Company” or “BioStem”),…

    Read More Ernst & Young (EY) US Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award finalistContinue

  • Press Release

    BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results

    ByJohn Garica May 12, 2025May 20, 2025

    May 12, 2025 POMPANO BEACH, Fla., May 12, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM) (the “Company” or “BioStem”), a leading MedTech company focused on the development, manufacture,…

    Read More BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial ResultsContinue

  • Press Release

    BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting

    ByJohn Garica May 1, 2025

    May 01, 2025 07:00 ET | Company to co-exhibit with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management. Three accepted scientific posters will feature BioStem’s advanced…

    Read More BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring MeetingContinue

  • Press Release

    BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million

    ByJohn Garica April 15, 2025April 15, 2025

    POMPANO BEACH, Fla., April 14, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM) (the “Company” or “BioStem”), a leading MedTech company focused on the development, manufacture, and commercialization of…

    Read More BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 MillionContinue

Page navigation

Previous PagePrevious 1 2 3 4 5 6 Next PageNext
BioStem Technologies
  • Home
  • Our Science
  • Products
  • Resources
  • About Us
  • Contact Us
  • Patents

© 2024 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.

For screen reader problems with this website, please call (954) 380-8342 for assistance.

Linkedin Instagram X

FAQs
Careers
Terms and Conditions
Privacy Policy
Shipping Policy
Refund Policy
Cookie Policy

  • Home
  • Our Science
  • Products
    • VENDAJE®
    • VENDAJE AC®
    • VENDAJE OPTIC®
    • American Amnion
  • Resources
  • About Us
    • Careers
    • Events